Parada GJD, Armendáriz BI, Martínez RHR

Language: Spanish
References: 16
Page: 363-367
PDF size: 200.20 Kb.

ABSTRACT

Introduction: Anti-NMDA receptor (NMDAR) encephalitis is an autoimmune or paraneoplastic disorder commonly associated with ovarian, lung, breast and testicular tumors, or even in patients without a tumor. Clinical manifestations consist mainly in psychiatric disturbances, memory deficits and speech impairment. The diagnosis is performed with detection of anti-NMDAR antibodies in CSF. Imaging studies are important, because 38% of the patients have identifiable tumors in lung, ovary and testicles. Most patients respond well to immunotherapy, tumor removal, or both.
Case Report: A 33-year-old woman presented with an acute psychotic episode, initially treated with antipsychotic drugs, then she developed symptoms that suggested neuroleptic malignant syndrome (NMS). Afterwards she presented akinetic mutism, hands tremor, orofacial dyskinesias and seizures. Blood test showed increased levels of serum CK. Head CT and MRI findings were normal. CSF showed pleocytosis. Pelvic CT revealed an image consistent with ovarian teratoma and anti-NMDAR antibodies tested positive in CSF. Treatment was started with immunosuppression, tumor removal and plasmapheresis, showing improvement in 4 weeks.
Conclusion: This case illustrates that anti-NMDAR encephalitis is a poorly identified entity in our settings. Because patients present with psychiatric symptoms, they can be managed initially with neuroleptic agents, without showing improvement and with the possibility of developing NMS. Despite the severity of the disease, there is a possibility of improvement with intensive care and immunotherapy.

REFERENCES

1. Titulaer M, McCracken L, Gabilondo I, Armangué T, Glaser G, Iizuka T, Honig L, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12: 157-65.

2. Gable M, Sheriff H, Dalmau J, Tilley D, Glaser D. The Frequency of Autoimmune N-Methyl-D-Aspartate Receptor Encephalitis Surpasses That of Individual Viral Etiologies in Young Individuals Enrolled in the California Encephalitis Project. Clin Infect Dis 2012; 54(7): 899-904.

3. Dalmau J, Lancaster E, Martínez-Hernandez E, Rosenfeld MR, Balice- Gordon R: Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10: 63-74.

4. Dalmau J, Gleichman A, Hughes E, Rossi J, Peng X, Lai M, Scott K Dessain S, Rosenfeld M, Balice-Gordon R, Lynch D. Anti-NMDAreceptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7(12): 1091-8.

5. Florance N, Davis R, Lam C, Szperka C, Zhou L, Ahmad S, Campen C, et al. Anti–N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis in Children and Adolescents. Ann Neurol 2009; 66(1): 11-18.

6. Bottoni T. Neuroleptic Malignant Syndrome: A Brief Review. Hosp Physician 2002; 38(3): 58-63.

7. Straw J, Keck P, Caroff S. Neuroleptic Malignant Syndrome. Am J Psychiatry 2007; 164(6): 870-67.

8. Balzan M. The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity. Postgrad Med J 1998; 74: 72-6.

9. Guzé B, Baxter L. Current concepts neuroleptic malignant syndrome. N Engl J Med 1985; 313(3): 163-6.

10. Sansing L, Tuzun E, Ko M, Baccon J, Lynch D, Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007; 3(5): 291-6.

11. Mann A, Phil M, Mata Machado N, Liu N, Mazin A, Silver K, Afzal K:A Multidisciplinary Approach to the Treatment of Anti-NMDA- Receptor Antibody Encephalitis: A Case and Review of the Literature. J Neuropsychiatry Clin Neurosc 2012; 24: 247-54.

12. Tachibana N, Ikeda S: Localization of NMDAR-related epitopes in ovarian teratoma: comparison between patients and controls. Rinsho Shinkeigaku 2012; 52(11): 982-4.

13. Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014; 13(2): 167-77.

14. Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012; 79(11): 1094-100.

15. Pham H, Daniel-Johnson J, Stotler B, Stephens H, Schwartz J. Therapeutic Plasma Exchange for the Treatment of Anti-NMDA Receptor Encephalitis. J Clin Apher 2011; 26: 320-5.

16. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61(1): 25-36.